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Methods
A systematic literature review was conducted using the
main electronic databases for health sciences and health
economic evaluations, including PubMed, Cochrane Library,
the British National Health Service Economic Evaluation
Databases and EconLit. Peer-reviewed full economic evalua-
tions published in English or German between January 2004
and November 2015 were considered for review. Eligible
were studies including either a trial-based cost-effectiveness
analysis or a simulation-based cost-effectiveness analysis of an
obesity prevention targeting preschool children and/or their
parents.
Results
Of the 728 studies identified in the initial search, 717 were
excluded after scrutiny of the abstracts. The remaining 11
articles were retained for subsequent detailed assessment;
among those, six were in line with our eligibility criteria and
were included for analysis. They included five intervention
studies, of which four were (cluster-) randomised trials and
one a quasi-experimental intervention study. The sixth study
was based on a simulation study conducted on secondary data.
The descriptive quality assessment of the included economic
evaluations presented varying degrees of integrity and
completion.
Conclusions
While the need for cost-effectiveness studies on obesity
prevention programmes in early childhood is immense, only
a few studies of varying quality have been conducted.
Moreover, due to methodological weaknesses, they have
provided only limited information for policy makers. We
elaborate reasons for the limitations of these studies and offer
guidance for designing better economic evaluations of early
obesity prevention.
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Background
This study evaluates the cost-benefits of the ‘Planning Health
in School’ programme (PHS-pro), which was implemented for
one-year in a follow-up non-randomized parallel-group trial
that promoted healthy eating and active living in Portuguese
children of 10-14 years.
Methods
Anthropometric outcomes (height, weight, waist circumfer-
ence- WC, BMI and waist-height-ratio- WHtR) and behaviour
changes in 219 intervention children (IC) were compared to
230 controls children (CC). A standard economic evaluation
was used to determine the cost-benefits of the intervention,
following the societal perspective approach. PHS-pro inter-
vention costs were estimated and compared to the direct costs
of treating obese adults in Portugal based on a Portuguese
study (Ribeiro V. 2010). The net benefit was measured by
subtracting the delivery costs of the intervention per child
from the total averted medical costs associated to treat an adult
obese in Portugal.
Results
After PHS-pro, the IC grew significantly more than the CC
(p < 0.001), the WC was significantly lower in the IC (-0.4 cm)
whereas CC increased (+0.3 cm; p = 0.015), and the WHtR of
IC showed a significant reduction (p = 0.002) compared with
CC.
PHS-pro costs were estimated in E8123.38 with an average
intervention cost of E37.09/child to attend to the programme.
This is much lower than the average direct costs for treating an
adult obese in Portugal which was calculated in E3849.15/year.
These costs are equivalent to implementing the PHS-pro in
104 children. The PHS-pro net benefit was positive in
E3812.06 as the monetary benefits clearly overcame the
monetary costs.
Conclusions
The findings provided evidence that the PHS-pro cost-benefits
were economically feasible. The PHS-pro can be of beneficial
investment to prevent overweight over in childhood and
adolescence, developmental stages that determine adulthood
free of chronic diseases.
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Background
Childhood obesity is a major public health concern. Given the
individual and societal consequences of childhood obesity,
decision-makers are in need of cost-effective prevention
strategies. The aim was to assess the costs and cost-
effectiveness of a novel primary prevention program targeting
pre-school children attending child health centers in Sweden.
Methods
The economic evaluation is based on the PRIMROSE cluster-
randomized controlled trial aiming to establish healthy eating
and physical activity among preschool children (9-48 months
of age) through motivational interviewing applied by trained
nurses at child health centers. The cost-effectiveness is assessed
over the trial period taking a societal perspective. The primary
outcome of this trial is BMI at age 4. Cost data was
prospectively collected alongside the trial. To account for
uncertainty, bootstrapping techniques and sensitivity analyses
were carried out.
Results
The mean total costs of the PRIMROSE intervention was 4067
SEK per child. During preschool years direct costs mainly consist
of training costs and costs for the additional time used by child
health center nurses to implement the intervention compared to
usual care. Early indirect costs mainly consist of parents’ absence
from work due to their participation in the intervention. Based
the trial-based economic evaluation the incremental cost-
effectiveness ratio was 1981 SEK per 0.1 BMI unit avoided.
Conclusions
This health economic evaluation is among the first European
economic evaluations of an early childhood obesity prevention
intervention. A simulation study incorporating the life time
societal impact is planned to capture all relevant costs and
effect.
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Background
There have been a number of epidemics affecting infants and
young children across Europe these past years (measles, polio,
rubella, etc.). Most of the new infections in the population
could have been avoided if the existing vaccines were
administered in the communities. The information provided
by public health experts doesn’t seem to be convincing enough
for authorities to implement the vaccination recommendations
in the population. Since the mid-20th century, economic
evaluations have been used to determine the optimal allocation
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of resources in different fields (education, road traffic safety,
etc.), the use of economic evaluations have also been extended
to the health sector. This presentation will focus on how
economic evaluation can complement traditional epidemiolo-
gical studies and contribute to facilitate the decision making
process.
Methods
There are different methodologies for economic evaluations,
there is a growing literature that successfully addresses the
monetary quantification of the overall impacts of adverse
health risk factors and public health interventions. The focus
here is on cost-effectiveness analyses of vaccine preventable
diseases in early childhood. A systematic literature review has
been performed using the main electronic data bases for health
sciences and health economic evaluations including PubMed,
Cochrane Library and EconLit.
Results and Conclusions
Economic evaluations may contribute to enhance the effec-
tiveness of decision making by providing information on
optimal allocation of resources. In times of austerity, economic
evaluations help to determine the most effective strategies and
as such set priorities. However, it is essential to adopt a
multidisciplinary approach in order to develop a more robust
and comprehensive framework for health assessment in the
decision making process.
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